ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Loncastuximab Tesirine Versus Glofitamab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma After Two or More Lines of Systemic Therapy: A Matching-Adjusted Indirect Comparison
Nov 19, 2024, 16:00 PM
«
941
942
943
944
(current)
945
946
947
948
949
950
»